FGF23 and obesity due to melanocortin 4 receptor deficiency: Furthermore, high FGF23 levels were also significantly associated with the future development of anemia in patients with low disease severity (e.g., with well-controlled BP, no diabetes, no obesity, and low comorbid conditions).